The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
Crossref DOI link: https://doi.org/10.1186/s40360-017-0130-0
Published Online: 2017-05-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Chih-Jen
Hung, Jen-Yu
Tsai, Ming-Ju
Wu, Kuan-Li
Liu, Ta-Chih
Chou, Shah-Hwa
Lee, Jui-Ying
Hsu, Jui-Sheng
Huang, Ming-Shyan
Chong, Inn-Wen
Funding for this research was provided by:
Kaohsiung Medical University (KMUH97-7G60)
Kaohsiung Municipal Ta-Tung Hospital (kmtth-104-021)